In the world of research liquids, Cabergoline is among one that is teaching scientists quite a bit. They have been studying the effects on numerous test subjects, but the ones that are showing the most promise in terms of research are rats. Researchers are able to see the results quickly, and change their experiments minimally to learn more about what the liquid itself is doing to the test subject's body. The benefits that Cabergoline could offer in terms of knowledge are growing with each new experiment that is being performed.

What Does Cabergoline Interact With?

First discovered in 1981, and patented in 1985, Cabergoline is a synthetic liquid that originated with researchers in Italy. This ergot derivative has shown impressive results in inhibiting prolactin cells on D2 receptors for dopamine. Researchers are regularly using this as a first line of defense when managing prolactins, because this research liquid seems to stick to more D2 receptors than other research liquids in the same family. However, it also sticks with other receptors, such as D3 and D4 receptors, and some of the 5-HT receptors.

What Are the Specifications of Cabergoline?

So far, researchers have discovered that Cabergoline has a half-life that is between 63 and 69 hours, allowing for researchers to perform long-term experiments and see how different test subjects and their cells react to Cabergoline exposure. Once the liquid starts to break down in preparation to exit the body, researchers have found the majority of the remnants to be excreted in the feces of the test subject, instead of the urine. There is very little information on whether or not this research liquid is safe during pregnancy, so those experiments are yet to come. However, rats have shown that it is crossing over into their milk, so it is not recommended to be experimented on during lactation. When it was used during lactation, it did show that the research liquid suppressed the milk production in the female rats, and has since been used to help treat false pregnancies in dogs so help dry up the milk supply.

What Side Effects Have Been Common with Cabergoline?

Researchers have found that most of the side effects that come along with exposure to Cabergoline are totally dependent on the dosage the test subject is exposed to. The more research liquid the rat was exposed to, the higher its chances of having one of these side effects. The most common side effects were nausea, dry mouth, low blood pressure, and constipation. Some of the less common side effects included disturbances in the test subject's sleeping cycles (either trouble sleeping or trouble staying awake), vertigo, irregular heartbeats, depression, and edema. Researchers also noticed that some of the test subjects also had increases in their levels of liver enzymes, but showed no adverse side effects of these increases.

Cabergoline is a very valuable liquid in terms of what it can teach researchers. They are able to see the differences that each dose can make on different cells over longer times than many other research liquids. The side effects that researchers are seeing with exposure to Cabergoline are minimal in comparison to the side effects that come with many of the ailments this research liquid is teaching them about; allowing them to see what damage is being done to the body by the ailments directly. This is helping researchers learn more about the body's response to these ailments, and could help uncover a way to treat them in the future for these test subjects.

DISCLAIMER: Cabergoline is not intended for human use or human consumption in any form. Exposure to this research liquid could cause harm, and should be avoided at all costs. These research liquids are for research purposes only, and should not be used for any other circumstance.